In addition, levels of angiotensin-converting enzyme 2 (ACE2), the reported host receptor of the virus responsible for COVID-19 (SARS-CoV-2), have been observed to be increased in patients with COPD [11]. This evidence concerns the gene ACE2 and COVID-19.